These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 34043978)
1. The Multifaceted Effects of Breast Cancer on Tumor-Draining Lymph Nodes. Jana S; Muscarella RA; Jones D Am J Pathol; 2021 Aug; 191(8):1353-1363. PubMed ID: 34043978 [TBL] [Abstract][Full Text] [Related]
2. Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node. van Pul KM; Vuylsteke RJCLM; van de Ven R; Te Velde EA; Rutgers EJT; van den Tol PM; Stockmann HBAC; de Gruijl TD J Immunother Cancer; 2019 May; 7(1):133. PubMed ID: 31118093 [TBL] [Abstract][Full Text] [Related]
3. Molecular patterns of cancer colonisation in lymph nodes of breast cancer patients. Chatterjee G; Pai T; Hardiman T; Avery-Kiejda K; Scott RJ; Spencer J; Pinder SE; Grigoriadis A Breast Cancer Res; 2018 Nov; 20(1):143. PubMed ID: 30458865 [TBL] [Abstract][Full Text] [Related]
4. Low mutation and neoantigen burden and fewer effector tumor infiltrating lymphocytes correlate with breast cancer metastasization to lymph nodes. Wang Z; Liu W; Chen C; Yang X; Luo Y; Zhang B Sci Rep; 2019 Jan; 9(1):253. PubMed ID: 30670769 [TBL] [Abstract][Full Text] [Related]
5. Role of lymphatic vessels in tumor immunity: passive conduits or active participants? Lund AW; Swartz MA J Mammary Gland Biol Neoplasia; 2010 Sep; 15(3):341-52. PubMed ID: 20835756 [TBL] [Abstract][Full Text] [Related]
6. Lymphatic system regulation of anti-cancer immunity and metastasis. Lei PJ; Fraser C; Jones D; Ubellacker JM; Padera TP Front Immunol; 2024; 15():1449291. PubMed ID: 39211044 [TBL] [Abstract][Full Text] [Related]
7. Plasmacytoid dendritic cells (PDC) are the major DC subset innately producing cytokines in human lymph nodes. Cox K; North M; Burke M; Singhal H; Renton S; Aqel N; Islam S; Knight SC J Leukoc Biol; 2005 Nov; 78(5):1142-52. PubMed ID: 16260587 [TBL] [Abstract][Full Text] [Related]
8. Chemokine and chemokine receptors: a comparative study between metastatic and nonmetastatic lymph nodes in breast cancer patients. Razmkhah M; Jaberipour M; Safaei A; Talei AR; Erfani N; Ghaderi A Eur Cytokine Netw; 2012; 23(3):72-7. PubMed ID: 23078970 [TBL] [Abstract][Full Text] [Related]
9. Heterogeneic expression of estrogen receptor between the primary tumor and the corresponding involved lymph nodes in patients with node-positive breast cancer and its implications in patient outcome. Iguchi C; Nio Y; Itakura M J Surg Oncol; 2003 Jun; 83(2):85-93. PubMed ID: 12772201 [TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin G expression and its potential role in primary and metastatic breast cancers. Ma C; Wang Y; Zhang G; Chen Z; Qiu Y; Li J; Luo J; Huang B; Jiang C; Huang G; Wan X; Korteweg C; Gu J Curr Mol Med; 2013 Mar; 13(3):429-37. PubMed ID: 23331015 [TBL] [Abstract][Full Text] [Related]
11. Patterns of supraclavicular area failure after mastectomy in breast cancer patients: implications for target volume delineation. Lin PC; Lin XJ; Li JL; Lin FF; Zhuang QY; Tang LR; Huang YX; Zhang XQ; Wu JX J Int Med Res; 2020 Sep; 48(9):300060520953315. PubMed ID: 32938273 [TBL] [Abstract][Full Text] [Related]
12. Stages of the development of immunologic response in regional lymph nodes draining breast cancer. Kozlowski H; Hrabowska M Neoplasma; 1978; 25(4):445-52. PubMed ID: 308619 [TBL] [Abstract][Full Text] [Related]
13. Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients. Zuckerman NS; Yu H; Simons DL; Bhattacharya N; Carcamo-Cavazos V; Yan N; Dirbas FM; Johnson DL; Schwartz EJ; Lee PP Int J Cancer; 2013 Jun; 132(11):2537-47. PubMed ID: 23136075 [TBL] [Abstract][Full Text] [Related]
14. Functional analysis of individual cells and microenvironment of breast cancer-draining lymph nodes. Zurgil N; Deutsch A; Afrimzon E; Shafran Y; Tirosh R; Sandbank J; Pappo I; Deutsch M Cancer Sci; 2008 May; 99(5):936-45. PubMed ID: 18325047 [TBL] [Abstract][Full Text] [Related]
15. Intratumor expanded T cell clones can be non-sentinel lymph node derived in breast cancer revealed by single-cell immune profiling. Jiao S; Xiong Q; Yan M; Zhan X; Yang Z; Peng C; Sun B; Pang D; Liu T J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 34992092 [TBL] [Abstract][Full Text] [Related]
16. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer. Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521 [TBL] [Abstract][Full Text] [Related]
18. Relationship of CD44+CD24-/low breast cancer stem cells and axillary lymph node metastasis. Wei W; Hu H; Tan H; Chow LW; Yip AY; Loo WT J Transl Med; 2012 Sep; 10 Suppl 1(Suppl 1):S6. PubMed ID: 23046710 [TBL] [Abstract][Full Text] [Related]
19. Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer. Ghaffari A; Hoskin V; Turashvili G; Varma S; Mewburn J; Mullins G; Greer PA; Kiefer F; Day AG; Madarnas Y; SenGupta S; Elliott BE Breast Cancer Res; 2019 Jan; 21(1):12. PubMed ID: 30678714 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of primary breast tumors and tumor-draining lymph nodes by means of the T-cell costimulatory molecule OX-40. Ramstad T; Lawnicki L; Vetto J; Weinberg A Am J Surg; 2000 May; 179(5):400-6. PubMed ID: 10930490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]